|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: SPATIALIZER AUDIO LABORATORIES INC, 10-Q, 2000-11-07 |
Next: NAPRO BIOTHERAPEUTICS INC, 8-K, 2000-11-07 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 1,518,781
<SECURITIES> 0
<RECEIVABLES> 580,000
<ALLOWANCES> 0
<INVENTORY> 12,993
<CURRENT-ASSETS> 2,168,411
<PP&E> 884,673
<DEPRECIATION> 550,583
<TOTAL-ASSETS> 2,542,271
<CURRENT-LIABILITIES> 922,426
<BONDS> 0
0
1,030
<COMMON> 467,530
<OTHER-SE> 1,151,285
<TOTAL-LIABILITY-AND-EQUITY> 2,542,271
<SALES> 1,665,829
<TOTAL-REVENUES> 1,665,829
<CGS> (168,088)
<TOTAL-COSTS> (168,088)
<OTHER-EXPENSES> (1,091,654)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (25,953)
<INCOME-PRETAX> 430,660
<INCOME-TAX> (44,271)
<INCOME-CONTINUING> 386,389
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 386,389
<EPS-BASIC> .01
<EPS-DILUTED> .01
</TABLE>
|
|